ROR2 and cancer: Experimental blocking of Tyrosine‐protein kinase transmembrane receptor (ROR2) receptors reversed the positive effect of WNT5A in cancer metastases [34] and may induce dormancy in bone in a WNT5A/ROR2‐dependent manner [25].